| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |